BALANCE SHEETS - USD ($)	Sep. 30, 2019	Sep. 30, 2018
CURRENT ASSETS:
Cash and cash equivalents	$ 8,444,774	$ 10,310,044
Receivables	62,765	118,657
Prepaid expenses	524,953	364,622
Inventory used for R&D and manufacturing	782,363	645,238
Total current assets	9,814,855	11,438,561
Plant, property and equipment	15,825,636	16,218,851
Patent costs, net	311,586	258,093
Deposits	1,670,917	1,670,917
Total Assets	27,622,994	29,586,422
CURRENT LIABILITIES:
Accounts payable	1,586,478	5,743,913
Accrued expenses	34,432	205,310
Due to employees	709,442	764,941
Derivative instruments, current portion	674,442	2,498,606
Other current liabilities	14,956	14,029
Total current liabilities	3,019,750	9,226,799
Derivative instruments, net of current portion	5,813,868	6,818,458
Lease liability	13,508,156	13,379,962
Deferred revenue	125,000	126,795
Other liabilities	22,553	33,492
Total liabilities	22,489,327	29,585,506
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY
Preferred stock, $.01 par value- 200,000 shares authorized; -0- shares issued and outstanding	0	0
Common stock, $.01 par value - 600,000,000 shares authorized; 35,231,776 and 28,034,487 shares issued and outstanding at September 30, 2019 and 2018, respectively	352,318	280,346
Additional paid-in capital	358,507,603	331,312,184
Accumulated deficit	(353,726,254)	(331,591,614)
Total stockholders' equity	5,133,667	916
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 27,622,994	$ 29,586,422